Press Release

Global Chromhidrosis Treatment Market to Grow at a Healthy Pace During 2021-2026, Driven by the Increasing Prevalence of Benign Chronic Conditions

Global Chromhidrosis Treatment Market

According to a new report by EMR titled, ‘Global Chromhidrosis Treatment Market Report and Forecast 2021-2026’, the global market for chromhidrosis treatment is being aided by the rising skin diseases treatment market, which is expected to grow at a CAGR of 3% during 2021-2026 to attain USD 23 billion by 2026.

The global market for chromhidrosis treatment is anticipated to witness a significant growth in the forecast period owing to factors like the increasing prevalence of benign chronic conditions. Increasing incomes and an ageing demographic are key contributors to this increased demand. The anti-ageing properties of injections of botulinum toxin type A are facilitating its entry into the medical industry. A rise in regulatory approvals for drugs in North America is expected to fuel the market growth. Some of the major players of the market include Ipsen Group and AbbVie Inc (NYSE: ABBV).

In 2018, according to the American Society of Plastic Surgeons, an estimation of 6,437,378 Botox type A injection procedures were undertaken in the United States. In July 2021, the United States Food and Drug Administration (FDA) approved a supplemental Biologics License Application (sBLA) that supports expanded use of BOTOX® for the treatment of spasticity in paediatric patients two years of age and older, including those with lower limb spasticity caused by cerebral palsy. Such developments are expected to support the market growth of chromhidrosis treatment.

Market Analysis by Disease Type, Treatment Type, Application, End Use, and Region:

  • The market, based on disease type, can be divided into apocrine chromhidrosis, eccrine chromhidrosis, and pseudochromhidrosis, among others.
  • Based on treatment type, the market is segmented into botox, liposuction, surgery, and home remedies, among others.
  • Based on the route of administration, the market is divided into topical and parental, among others.
  • The major end uses of the industry are hospitals and clinics and specialty and dermatology clinics, among others.
  • The regional markets for chromhidrosis treatment include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Key Findings of the Report:

  • The chromhidrosis treatment industry is being driven by the rising prevalence of benign chronic conditions.
  • The rising customer incomes and ageing demographics are aiding the market growth.
  • The increased usage of botulinum toxin type A as an anti-aging treatment is propelling the market growth.
  • The market is expected to witness further expansion in the coming years due to a huge increase in the number of regulatory approvals for drugs, especially in the North American region.

Key Offerings of the Report:

  • The EMR report gives an overview of the global market for chromhidrosis treatment for the periods (2016-2020) and (2021-2026).
  • The report also offers the historical (2016-2020) and forecast (2021-2026) markets for the types, treatment types, routes of administration, end uses, and major regions of chromhidrosis treatment.
  • The report analyses the market dynamics, covering the key demand and price indicators in the market, along with an assessment of the SWOT and Porter’s Five Forces models.

The major players in the global chromhidrosis treatment market are Meditox Co., Inc, Ipsen Group, and AbbVie Inc, among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER